Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

NovoCure Limited (NVCR) had Revenue of $167.20M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$167.20M
Net Income	$-37.27M
Cost of Goods Sold	$44.73M
Gross Profit	$122.47M
Operating Expenses	$203.22M
Operating Income	$-36.02M
Non-Operating Income/Expense	$6.00M
Pre-Tax Income	$-30.02M
Normalized Pre-Tax Income	$-30.02M
Income after Taxes	$-37.27M
Income from Continuous Operations	$-37.27M
Consolidated Net Income/Loss	$-37.27M
Normalized Income after Taxes	$-37.27M
EBIT	$-36.02M
EBITDA	$-38.76M
Weighted-Average Shares Outstanding (Basic)	111.91M
Weighted-Average Shares Outstanding (Diluted)	111.91M
Earnings per Share (EPS) (Basic)	$-0.33
Earnings per Share (EPS) (Diluted)	$-0.33
Balance Sheet Financials
Current Assets	$1.20B
Property, Plant, and Equipment	$100.53M
Long-Term Assets	$161.34M
Total Assets	$1.36B
Current Liabilities	$776.01M
Long-Term Debt	$194.64M
Long-Term Liabilities	$243.85M
Total Liabilities	$1.02B
Common Equity	$341.33M
Tangible Shareholders Equity	$341.33M
Shareholders Equity	$341.33M
Common Shares Outstanding	111.98M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-31.03M
Cash Flow from Investing Activities	$100.95M
Cash Flow from Financial Activities	$108.15M
Beginning Cash	$166.09M
End Cash	$344.64M
Increase/Decrease in Cash	$178.54M
Stock-Based Compensation	$85.02M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.55
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	2.21
Gross Margin	73.25%
Operating Margin	-21.54%
EBIT Margin	-21.54%
EBITDA Margin	--
Pre-Tax Profit Margin	-17.96%
Profit Margin	-22.29%
Free Cash Flow	$-52.78M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	1.14
Receiveable Turnover	1.34
Days Sales in Receivables	67.14
Return on Equity	-10.92%
Return on Tangible Equity	-10.92%
Return on Assets	-2.74%
Return on Investments	-6.95%
Book Value Per Share	$3.05
Free Cash Flow per Share	$-0.47
Operating Cash Flow per Share	$-0.28

Data from Zacks Investment Research, Inc.